Edition:
United Kingdom

Interpace Diagnostics Group Inc (IDXG.OQ)

IDXG.OQ on NASDAQ Stock Exchange Capital Market

1.06USD
5:15pm BST
Change (% chg)

$0.01 (+0.95%)
Prev Close
$1.05
Open
$1.04
Day's High
$1.06
Day's Low
$1.04
Volume
6,842
Avg. Vol
41,288
52-wk High
$1.80
52-wk Low
$0.77

Chart for

About

Interpace Diagnostics Group, Inc., formerly PDI, Inc., is focused on developing and commercializing molecular diagnostic tests principally focused on early detection of high potential progressors to cancer and leveraging the latest technology and personalized medicine for patient diagnosis and management. The Company operates... (more)

Overall

Beta: 2.18
Market Cap(Mil.): $28.76
Shares Outstanding(Mil.): 28.19
Dividend: --
Yield (%): --

Financials

  IDXG.OQ Industry Sector
P/E (TTM): -- 26.78 22.72
EPS (TTM): -0.52 -- --
ROI: -30.75 9.36 7.73
ROE: -35.68 13.35 12.99

BRIEF-Interpace Diagnostics Enters Agreement With Integrated Health Systems

* INTERPACE DIAGNOSTICS ENTERS AGREEMENT WITH ONE OF THE LARGEST, INTEGRATED HEALTH SYSTEMS IN THE US

18 Apr 2018

BRIEF-Interpace Diagnostics Announces Agreement With Acupath Laboratories

* INTERPACE DIAGNOSTICS ANNOUNCES AGREEMENT WITH ACUPATH LABORATORIES

28 Mar 2018

BRIEF-Interpace Diagnostics Announces Additional Coverage of Thyroid Tests

* INTERPACE DIAGNOSTICS - 4 ADDITIONAL BLUE CROSS BLUE SHIELD PLANS AGREED TO COVER BOTH OF INTERPACE'S PROPRIETARY THYROID TESTS, THYGENX AND THYRAMIR Source text for Eikon: Further company coverage:

08 Mar 2018

Earnings vs. Estimates